SC Pharmaceuticals Inc (SCPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.78 -0.26 (-8.55%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.90 +0.12 (+4.32%) 18:12 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
Sales | 3,796 | 1,638 | 2,063 | 0 | 0 |
Cost of Goods | 1,079 | 354 | 605 | N/A | N/A |
Gross Profit | 2,717 | 1,284 | 1,458 | N/A | N/A |
Operating Expenses | 17,635 | 15,384 | 13,617 | 9,501 | 9,995 |
Operating Income | -14,839 | -13,746 | -11,554 | -9,501 | -9,995 |
Interest Expense | 2,060 | 2,010 | 1,961 | 1,960 | 377 |
Other Income | 1,265 | 1,602 | 2,305 | 2,213 | 210 |
Pre-tax Income | -15,634 | -14,154 | -11,210 | -9,248 | -10,162 |
Net Income Continuous | -15,634 | -14,154 | -11,210 | -9,248 | -10,162 |
Net Income | $-15,634 | $-14,154 | $-11,210 | $-9,248 | $-10,162 |
EPS Basic Total Ops | -0.41 | -0.36 | -0.30 | -0.30 | -0.37 |
EPS Basic Continuous Ops | -0.40 | -0.37 | -0.30 | -0.29 | -0.37 |
EPS Diluted Total Ops | -0.41 | -0.36 | -0.30 | -0.30 | -0.37 |
EPS Diluted Continuous Ops | -0.40 | -0.37 | -0.30 | -0.29 | -0.37 |
EPS Diluted Before Non-Recurring Items | -0.41 | -0.36 | -0.30 | -0.30 | N/A |
EBITDA(a) | $-15,035 | $-13,637 | $-11,449 | $-9,812 | $-9,877 |